Sentinel Lymph Node Detection Using Laser-Assisted Indocyanine Green Dye Lymphangiography in Patients with Melanoma

Abstract

INTRODUCTION Sentinel lymph node (SLN) biopsy is a vital component of staging and management of multiple cancers. The current gold standard utilizes technetium 99 (tech99) and a blue dye to detect regional nodes. While the success rate is typically over 90%, these two methods can be inconclusive or inconvenient for both patient and surgeon. We evaluated a new technique using laser-assisted ICG dye lymphangiography to identify SLN. METHODS In this retrospective analysis, we identified patients with melanoma who were candidates for SLN biopsy. In addition to tech99 and methylene blue, patients received a dermal injection of indocyanine green (ICG). The infrared signal was detected with the SPY machine (Novadaq), and nodes positive by any method were excised. RESULTS A total of 15 patients were evaluated, with 40 SLNs removed. Four patients were found to have nodal metastases on final pathology. 100% of these 4 nodes were identified by ICG, while only 75% (3/4) were positive for tech99 and/or methylene blue. Furthermore, none of the nodes missed by ICG (4/40) had malignant cells. CONCLUSION ICG dye lymphangiography is a reasonable alternative for locating SLNs in patients with melanoma. Prospective studies are needed to better ascertain the full functionality of this technique.

DOI: 10.1155/2013/904214

Extracted Key Phrases

4 Figures and Tables

Showing 1-10 of 15 references

A comparison of indocyanine green fluorescence imaging plus blue dye and blue dye alone for sentinel node navigation surgery in breast cancer patients

  • A Hirano, M Kamimura, K Ogura
  • 2012
1 Excerpt

Factors associated with false-negative sentinel lymph node biopsy in melanoma patients

  • C R Scoggins, R C G Martin, M I Ross
  • 2010
1 Excerpt

Statistics

0500201520162017
Citations per Year

130 Citations

Semantic Scholar estimates that this publication has received between 3 and 993 citations based on the available data.

See our FAQ for additional information.